255 results on '"Awada, Hussein"'
Search Results
2. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting
3. Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
4. Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis
5. Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
6. Molecular patterns identify distinct subclasses of myeloid neoplasia
7. High-grade large cell neuroendocrine carcinoma of the esophagus: a case report and review of the literature
8. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
9. A multimodal analysis of genomic and RNA splicing features in myeloid malignancies
10. Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report
11. Assessing the combination of magnetic field stimulation, iron oxide nanoparticles, and aligned electrospun fibers for promoting neurite outgrowth from dorsal root ganglia in vitro
12. Thrombocytosis and megakaryocyte changes associated with PRCA
13. Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia
14. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report
15. Molecular organization relationship of low-bandgap polymers at the air-water interface and in solid films
16. P726: TET2 ALLELIC BURDEN IMPRINTS A CONTEXT-DEPENDENT PROGNOSTIC SIGNIFICANCE OF ASXL1 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
17. Dexamethasone Dose and Early Postoperative Recovery after Mastectomy: A Double-blind, Randomized Trial
18. Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management
19. Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID-19
20. What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
21. The Heterogeneous Complexity of Myeloid Neoplasm: Multi-Level Approaches to Study the Disease
22. The Characteristics of Multiple Myeloma Patients Referred for CAR T-Cell Therapy
23. Incidence of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant
24. Factors That Predict Early Relapse Post Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients
25. Analysis of Factors That Predict Progression Free and Overall Survival Post Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients
26. Outcomes of CMV Infection in the Setting of Gastrointestinal Graft Vs. Host Disease in the Era of Pre-Emptive and Prophylactic Antiviral Therapy
27. Infectious Complications Following CAR T-Cell Therapy in Patients with Relapsed and Refractory Multiple Myeloma
28. Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia
29. The status of bladder cancer research worldwide, a bibliometric review and recommendations
30. Risk of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant
31. Dead and Deah-Box Helicases Other Than DDX41 Are Mutated in Myeloid Neoplasia
32. Deciphering Treatment Patterns in Non-Severe Aplastic Anemia: An International Observational Study
33. Chip-Derived Vs De Novo Treatment-Related Myeloid Neoplasms after Autologous Stem Cell Transplant for Lymphoid Disorders
34. Trisomy-6: The Ying and Yang of Chromosome 6 Aberrations
35. Long-Term Outcomes of Autologous Hematopoietic Cell Transplant of Multiple Myeloma: A 10 Year Follow up Study
36. Molecular Patterns Identify Distinct Subclasses of Myeloid Neoplasia
37. The Role of Corrected Dlco in Predicting Relapse and Mortality Post Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
38. Allogeneic Stem Cell Transplant for Myelodysplastic Syndrome in the New Molecular Era of IPSS-M
39. Validation of the CIBMTR Scoring System in Predicting Early Relapse of Multiple Myeloma Post Autologous Hematopoietic Cell Transplant
40. Long-Term Outcomes of Delayed Neutrophil Engraftment Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma
41. Multi-Omics Data Integration of Genomics and RNA-Splicing in Myeloid Neoplasia
42. Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement Inhibitors and Doacs
43. Validation of the Gatmo Score in Predicting Mortality Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients
44. Splicing Analysis Unveils Convergent Transcriptomic Pathways in U2AF1 S34 and Q157 Mutant Myeloid Neoplasia
45. Metabolic Dysfunctions Driven By PRPF8 Explain Cases with Ring Sideroblasts without SF3B1 Mutations: Similarity/ Differences of Genotype/ Phenotype Association
46. Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia
47. Intravenous Immunoglobulin Prophylaxis Is Associated with Decreased Rate of Infection-Related Hospitalizations in Multiple Myeloma Patients
48. Antineutrophil Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis With Mucosal Involvement Following COVID-19 Pneumonia
49. Fluorinated benzothiadiazole-based low band gap copolymers to enhance open-circuit voltage and efficiency of polymer solar cells
50. A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.